tradingkey.logo


tradingkey.logo


Translational Development Acquisition Corp

TDACU
10.574USD
0.0000.00%
取匕時間 ET15分遅れの株䟡
0.00時䟡総額
--盎近12ヶ月PER


Translational Development Acquisition Corp

10.574
0.0000.00%

詳现情報 Translational Development Acquisition Corp 䌁業名

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

Translational Development Acquisition Corpの䌁業情報


䌁業コヌドTDACU
䌚瀟名Translational Development Acquisition Corp
䞊堎日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)
埓業員数- -
蚌刞皮類Unit
決算期末- -
本瀟所圚地52 E 83Rd St.
郜垂NEW YORK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号10028
電話番号14132042769
りェブサむト
䌁業コヌドTDACU
䞊堎日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)

Translational Development Acquisition Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, Mar 8
曎新時刻: Sun, Mar 8
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Calamos Advisors LLC
2.17%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
Yakira Capital Management, Inc.
0.35%
Flow Traders U.S. LLC
0.08%
他の
94.49%
株䞻統蚈
株䞻統蚈
比率
Calamos Advisors LLC
2.17%
D. E. Shaw & Co., L.P.
2.03%
Schechter Investments
0.87%
Yakira Capital Management, Inc.
0.35%
Flow Traders U.S. LLC
0.08%
他の
94.49%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
2.17%
Hedge Fund
2.03%
Investment Advisor
1.27%
Research Firm
0.08%
他の
94.45%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
46
1.06M
6.17%
-13.84M
2025Q3
47
2.55M
14.76%
-12.35M
2025Q2
46
4.08M
23.66%
-10.95M
2025Q1
45
4.60M
26.65%
-10.31M
2024Q4
41
14.94M
86.63%
+14.94M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Calamos Advisors LLC
375.00K
2.17%
--
--
Sep 30, 2025
D. E. Shaw & Co., L.P.
350.00K
2.03%
--
--
Sep 30, 2025
Schechter Investments
150.64K
0.87%
--
--
Mar 31, 2025
Yakira Capital Management, Inc.
60.00K
0.35%
--
--
Sep 30, 2025
Flow Traders U.S. LLC
15.79K
0.09%
+1.56K
+10.96%
Sep 30, 2025
UBS Financial Services, Inc.
8.33K
0.05%
--
--
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™